IRulya Therapeutics (IRLA) Net Equity Issued and Repurchased (2019 - 2026)
IRulya Therapeutics' Net Equity Issued and Repurchased was $5.35 million in Q2 2026, up 79.2% from $2.99 million a year earlier but down 64.3% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, IRulya Therapeutics' Net Equity Issued and Repurchased was $23.75 million through Jun 30, 2026, up 672.8% year-over-year; for FY2025, it came in at $6.48 million.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -44.1% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $225,000 in FY2024 (+51.0%), $149,000 in FY2023 (-80.3%), $756,000 in FY2022 (-88.9%) and $6.81 million in FY2021 (-94.3%).
- Quarterly Net Equity Issued and Repurchased has moved between $10,000 (Q3 2023) and $14.99 million (Q1 2026) over five years.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q1 2024 (growth of 239.3%); the worst was Q3 2022 (a decline of 99.7%).
- Per Business Quant data, IRLA's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $14.99 million (Q1 2026), $2.03 million (Q4 2025) and $1.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 5.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.35 Mn |
| Mar 31, 2026 | 14.99 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 2.99 Mn |
| Mar 31, 2025 | 87,000.00 |
| Jun 30, 2024 | 35,000.00 |
| Mar 31, 2024 | 190,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 120,000.00 |
| Mar 31, 2022 | 622,000.00 |
| Dec 31, 2021 | 990,000.00 |
| Sep 30, 2021 | 4.71 Mn |
| Jun 30, 2021 | 672,000.00 |
| Mar 31, 2021 | 441,000.00 |
| Dec 31, 2020 | 47,000.00 |
API Access
IRulya Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();